Crystal structures of mouse and human RP105/MD-1 complexes reveal unique dimer organization of the toll-like receptor family

Journal of Molecular Biology

Volumn 413, Issue 4, 2011, Pages 815-825

  Ohto, Umeharu ^a   Miyake, Kensuke ^a   Shimizu, Toshiyuki ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

lipopolysaccharide; MD 1; MD 2; RP105; TLR4

Indexed keywords

HETERODIMER; MD 1 PROTEIN; RADIOPROTECTIVE 105 KDA PROTEIN; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 1; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 6; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ARTICLE; CARBOXY TERMINAL SEQUENCE; CRYSTAL STRUCTURE; CYTOPLASM; DIMERIZATION; HUMAN; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN INTERACTION; PROTEIN LOCALIZATION; SIGNAL TRANSDUCTION;

IVA;

EID: 80054851136     PISSN: 00222836     EISSN: 10898638     Source Type: Journal    
DOI: 10.1016/j.jmb.2011.09.020     Document Type: Article

References (36)

1. Janeway, C. A. & Medzhitov, R. (2002). Innate immune recognition. Annu. Rev. Immunol. 20, 197-216.
2. Gay, N. J. & Gangloff, M. (2007). Structure and function of Toll receptors and their ligands. Annu. Rev. Biochem. 76, 141-165.
3. Poltorak, A., He, X., Smirnova, I., Liu, M. Y., Van Huffel, C., Du, X. et al. (1998). Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science, 282, 2085-2088. (Pubitemid 29001265)
4. Angus, D. C., Linde-Zwirble, W. T., Lidicker, J., Clermont, G., Carcillo, J. & Pinsky, M. R. (2001). Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit. Care Med. 29, 1303-1310. (Pubitemid 32641789)
5. Nagai, Y., Akashi, S., Nagafuku, M., Ogata, M., Iwakura, Y., Akira, S. et al. (2002). Essential role of MD-2 in LPS responsiveness and TLR4 distribution. Nat. Immunol. 3, 667-672. (Pubitemid 34752476)
6. Miyake, K., Yamashita, Y., Hitoshi, Y., Takatsu, K. & Kimoto, M. (1994). Murine B-cell proliferation and protection from apoptosis with an antibody against a 105-kDa molecule - unresponsiveness of X-linked immunodeficient B-cells. J. Exp. Med. 180, 1217-1224. (Pubitemid 24289595)
7. Miyake, K., Yamashita, Y., Ogata, M., Sudo, T. & Kimoto, M. (1995). RP105, a novel B-cell surface-molecule implicated in B-cell activation, is a mimber of the leucine-rich repeat protein family. J. Immunol. 154, 3333-3340.
8. Miyake, K., Shimazu, R., Kondo, J., Niki, T., Akashi, S., Ogata, H. et al. (1998). Mouse MD-1, a molecule that is physically associated with RP105 and positively regulates its expression. J. Immunol. 161, 1348-1353. (Pubitemid 28380563)
9. Inohara, N. & Nunez, G. (2002). ML - a conserved domain involved in innate immunity and lipid metabolism. Trends Biochem. Sci. 27, 219-221. (Pubitemid 34655436)
10. Nagai, Y., Shimazu, R., Ogata, H., Akashi, S., Sudo, K., Yamasaki, H. et al. (2002). Requirement for MD-1 in cell surface expression of RP105/CD180 and B-cell responsiveness to lipopolysaccharide. Blood, 99, 1699-1705. (Pubitemid 34533044)
11. Ogata, H., Su, I., Miyake, K., Nagai, Y., Akashi, S., Mecklenbrauker, I. et al. (2000). The toll-like receptor protein RP105 regulates lipopolysaccharide signaling in B cells. J. Exp. Med. 192, 23-29. (Pubitemid 30470803)
12. Divanovic, S., Trompette, A., Atabani, S. F., Madan, R., Golenbock, D. T., Visintin, A. et al. (2005). Negative regulation of Toll-like receptor 4 signaling by the Toll-like receptor homolog RP105. Nat. Immunol. 6, 571-578. (Pubitemid 41710727)
13. Kobayashi, T., Takahashi, K., Nagai, Y., Shibata, T., Otani, M., Izui, S. et al. (2008). Tonic B cell activation by Radioprotective105/MD-1 promotes disease progression in MRL/lpr mice. Int. Immunol. 20, 881-891.
14. Jin, M. S., Kim, S. E., Heo, J. Y., Lee, M. E., Kim, H. M., Paik, S. G. et al. (2007). Crystal structure of the TLR1-TLR2 heterodimer induced by binding of a tri-acylated lipopeptide. Cell, 130, 1071-1082.
15. Kang, J. Y., Nan, X., Jin, M. S., Youn, S. J., Ryu, Y. H., Mah, S. et al. (2009). Recognition of lipopeptide patterns by Toll-like receptor 2-Toll-like receptor 6 heterodimer. Immunity, 31, 873-884.
16. Liu, L., Botos, I., Wang, Y., Leonard, J. N., Shiloach, J., Segal, D. M. & Davies, D. R. (2008). Structural basis of toll-like receptor 3 signaling with double-stranded RNA. Science, 320, 379-381. (Pubitemid 351555661)
17. Park, B. S., Song, D. H., Kim, H. M., Choi, B. S., Lee, H. & Lee, J. O. (2009). The structural basis of lipopolysaccharide recognition by the TLR4-MD-2 complex. Nature, 458, 1191-1195.
18. Jin, M. S. & Lee, J. O. (2008). Structures of the toll-like receptor family and its ligand complexes. Immunity, 29, 182-191.
19. Kumar, H., Kawai, T. & Akira, S. (2009). Toll-like receptors and innate immunity. Biochem. Biophys. Res. Commun. 388, 621-625.
20. Bell, J. K., Mullen, G. E., Leifer, C. A., Mazzoni, A., Davies, D. R. & Segal, D. M. (2003). Leucine-rich repeats and pathogen recognition in Toll-like receptors. Trends Immunol. 24, 528-533. (Pubitemid 37205203)
21. Kim, H. M., Park, B. S., Kim, J. I., Kim, S. E., Lee, J., Oh, S. C. et al. (2007). Crystal structure of the TLR4-MD-2 complex with bound endotoxin antagonist Eritoran. Cell, 130, 906-917. (Pubitemid 47332573)
22. Harada, H., Ohto, U. & Satow, Y. (2010). Crystal structure of mouse MD-1 with endogenous phospholipid bound in its cavity. J. Mol. Biol. 400, 838-846.
23. Ohto, U., Fukase, K., Miyake, K. & Satow, Y. (2007). Crystal structures of human MD-2 and its complex with antiendotoxic lipid IVa. Science, 316, 1632-1634. (Pubitemid 46982039)
24. Yoon, S. I., Hong, M., Han, G. W. & Wilson, I. A. (2010). Crystal structure of soluble MD-1 and its interaction with lipid IVa. Proc. Natl Acad. Sci. USA, 107, 10990-10995.
25. Reichlin, A., Gazumyan, A., Nagaoka, H., Kirsch, K. H., Kraus, M., Rajewsky, K. & Nussenzweig, M. C. (2004). A B cell receptor with two Igα cytoplasmic domains supports development of mature but anergic B cells. J. Exp. Med. 199, 855-865. (Pubitemid 38375205)
26. Blumenthal, A., Kobayashi, T., Pierini, L. M., Banaei, N., Ernst, J. D., Miyake, K. & Ehrt, S. (2009). RP105 facilitates macrophage activation by Mycobacterium tuberculosis lipoproteins. Cell Host Microbe, 5, 35-46.
27. Yoon, S. I., Hong, M. & Wilson, I.A. (2011). An unusual dimeric structure and assembly for TLR4 regulator RP105-MD-1. Nat. Struct. Mol. Biol. 18, 1028-1035.
28. Otwinowski, Z. & Minor, W. (1997). Processing of X-ray diffraction data collected in oscillation mode. Methods Enzymol. 276, 307-326. (Pubitemid 27085611)
29. Vonrhein, C., Blanc, E., Roversi, P. & Bricogne, G. (2007). Automated structure solution with autoSHARP. Methods Mol. Biol. 364, 215-230. (Pubitemid 350183137)
30. Collaborative Computational Project, Number 4. (1994). The CCP4 Suite: programs for protein crystallography. Acta Crystallogr., Sect. D: Biol. Crystallogr. 50, 760-763.
31. Emsley, P. & Cowtan, K. (2004). Coot: model-building tools for molecular graphics. Acta Crystallogr., Sect. D: Biol. Crystallogr. 60, 2126-2132. (Pubitemid 41742764)
32. Murshudov, G. N., Vagin, A. A. & Dodson, E. J. (1997). Refinement of macromolecular structures by the maximum-likelihood method. Acta Crystallogr., Sect. D: Biol. Crystallogr. 53, 240-255. (Pubitemid 27235885)
33. Vagin, A. & Teplyakov, A. (1997). MOLREP: an automated program for molecular replacement. J. Appl. Crystallogr. 30, 1022-1025. (Pubitemid 127485985)
34. Laskowski, R. A., Macarthur, M. W., Moss, D. S. & Thornton, J. M. (1993). PROCHECK: a program to check the stereochemical quality of protein structures. J. Appl. Crystallogr. 26, 283-291.
35. DeLano, W. L. (2008). The PyMOL Molecular Graphics System. DeLano Scientific LLC, Palo Alto, CA; http:// www.pymol.org.
36. Svergun, D. I. (1992). Determination of the regularization parameter in indirect-transform methods using perceptual criteria. J. Appl. Crystallogr. 25, 495-503.